ORLANDO, Fla., Oct. 26, 2007 (PRIME NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, Inc., announced that it has issued a second quarter research update on BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH).
Tony Telan, RedChip Research Analyst, wrote in the report:
"BioForce Nanosciences, Inc.(OTCBB:BFNH), a developer of nanotechnology instruments, consumables, and applications for the life sciences industry, announced the completion of a financing transaction valued up to $3.45 million. The transaction entailed sales to an institutional investor of Series A 8% Convertible Preferred Stock at $0.50 per share and a series of warrants with exercise prices ranging from $0.50 to $1.25 per share. Notably, the transaction is structured at a fixed price and therefore protects the interests of current shareholders.
"In summary, we continue to believe BFNH offers a compelling investment opportunity for those seeking exposure to micro-cap nanotechnology equities. With a current market cap of less than $16 million, BFHN is undervalued given the expected trajectory of near-term revenue growth and the large ultimate market potential of the Company's product offering. Using sales of AFMs as a proxy for market size and assuming approximately 8,000 AFM sales to date yields a potential market of $1.3 billion (8,000 systems x $160,000 per system) for the NeN system, or $800 million assuming a lower sales target (5,000 systems). Note this analysis conservatively does not include 1) follow on sales of consumables (e.g. the "ink cartridge" and "paper"), 2) potential price increases for high throughput product enhancements or 3) intellectual property related to its ViriChip and Chip-on-a-Tip product development initiatives."
To receive a complimentary copy of the RedChip Visibility research update for BFNH, please visit:
http://www.redchip.com/visibility/about.asp?page=requestbfnh_q2_2007&from=newsbfnh10262007
About RedChip Companies, Inc.
RedChip Companies is an international small-cap research and financial public relations firm with offices in Beijing and Orlando and affiliates in New York and San Diego. RedChip delivers measurable results for its clients through its extensive international market expertise as well as its comprehensive platform of products: RedChip Research, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences held throughout the United States, RedChip Radio, and RedChip TV.
To learn more about RedChip's products and services please visit:
http://www.redchip.com/visibility/services.asp
Disclosures
The analysts contributing to this report do not hold any shares of BFNH. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. BFNH is a client of RedChip Visibility, a division of RedChip Companies. BFNH paid RedChip Visibility $32,400 for the RedChip Visibility Research Program, which includes this report. RedChip Visibility has been contracted by BFNH to increase investor awareness of BFNH to the small-cap equity community. These services may include investor conferences and digital and print distribution of BFNH investor related materials. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip was hired by the Company and receives a monthly fee of $5,500 and warrants to purchase 80,000 shares of the Company's common stock.